Tumor cells can secrete TGF-β, which directly induces the transformation of NK cells into innate lymphoid cell type 1 (ILC1) cells lacking cytotoxic function, inhibits the cytotoxicity mediated by the NK cell receptor NKG2D, promotes immune escape of tumor cells, and induces immune tolerance of tumor cells [121]. This evidence concerns the gene KLRK1 and neoplasm.